CY414A - Therapeutic compositions containing chhloridiazepoxide - Google Patents

Therapeutic compositions containing chhloridiazepoxide

Info

Publication number
CY414A
CY414A CY41467A CY41467A CY414A CY 414 A CY414 A CY 414A CY 41467 A CY41467 A CY 41467A CY 41467 A CY41467 A CY 41467A CY 414 A CY414 A CY 414A
Authority
CY
Cyprus
Prior art keywords
chhloridiazepoxide
compositions containing
therapeutic compositions
therapeutic
containing chhloridiazepoxide
Prior art date
Application number
CY41467A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CY414A publication Critical patent/CY414A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CY41467A 1961-10-17 1967-11-10 Therapeutic compositions containing chhloridiazepoxide CY414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US145782A US3122474A (en) 1961-10-17 1961-10-17 Chlordiazepoxide and clidinium halide composition and method of using same

Publications (1)

Publication Number Publication Date
CY414A true CY414A (en) 1967-11-10

Family

ID=22514521

Family Applications (1)

Application Number Title Priority Date Filing Date
CY41467A CY414A (en) 1961-10-17 1967-11-10 Therapeutic compositions containing chhloridiazepoxide

Country Status (6)

Country Link
US (1) US3122474A (en)
CY (1) CY414A (en)
ES (1) ES281617A1 (en)
FR (1) FR2156M (en)
GB (1) GB942889A (en)
MY (1) MY6400086A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
ES281617A1 (en) 1963-05-01
MY6400086A (en) 1964-12-31
GB942889A (en) 1963-11-27
US3122474A (en) 1964-02-25
FR2156M (en) 1963-11-18

Similar Documents

Publication Publication Date Title
MY6600079A (en) Fungicidal compositions
GB1000195A (en) Photosensitive compositions
CY355A (en) N-phenylamidine compounds
MY6500007A (en) Therapeutic compositions useful for inducing sleep
CY414A (en) Therapeutic compositions containing chhloridiazepoxide
IE26095L (en) Therapeutic compositions
IE25741L (en) Therapeutic composition
CA629101A (en) Chasse-neige
CY373A (en) Pyrazinoyl-guanidines
CA626565A (en) Therapeutic compositions containing 1-dehydro-6-methyl-cortisone or related compounds
CA24051S (en) Combine
IE26362L (en) Therapeutic compositions
CA23822S (en) Handmixer
CA611896A (en) Methylpolysiloxane therapeutic composition
IE25932L (en) Antitussive compositions
MY6700072A (en) Benzyloxyamines and compositions containing them
IE26363L (en) Therapeutic composition
IE25773L (en) Antiseptic preparation
IE26419L (en) Dibenzodiazepinone compounds
IE26100L (en) Dihydro-anthracene compounds
IE25009L (en) Therapeutic compositions
CA622220A (en) Classeur
IE26224L (en) Sugar compositions
IE25432L (en) Thionocarbonates
CY430A (en) 17alpha-Ethyl- and 17alpha-ethynyl-18-homo-19-nortestosterones